Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease [NA]
This completed clinical trial examines donor stem cell transplantation after conditioning therapy in patients with hematologic cancers, recu…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients
An observational analysis from a completed study examining voriconazole trough concentrations, pharmacogenomic factors, and clinical outcome…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating the combination of Beta-Glucan and Rituximab in young patients with relapsed or progressive leukemia or lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow transplantation in advanced hematologic cancers. The tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of bortezomib combined with vorinostat in high-risk myelodysplastic syndrome or acute myeloid leukemia has been terminated; re…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Melphalan in Patients With Neoplastic Meningitis [Phase 1]
Phase 1 trial of intrathecal melphalan in patients with neoplastic meningitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without monoclonal antibody therapy in leukemia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders [Phase 1]
Phase 1 study assessing decitabine with FR901228 (romidepsin) in patients with relapsed or refractory leukemia, myelodysplastic syndromes, a…
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Phase 1, Phase 2]
This clinical trial update indicates termination of a Phase 1/2 study evaluating arsenic trioxide with or without tretinoin in patients with…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia [Phase 2]
Phase 2 clinical trial update of combination chemotherapy followed by peripheral stem cell transplantation and interleukin-2 in acute leukem…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia [Phase 1]
This Phase 1 trial update reports completion of a chemotherapy regimen in combination with PSC-833 (valspodar) for children with refractory …
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Topotecan in Treating Children With Refractory Leukemia [Phase 1]
A Phase 1 clinical trial evaluating Topotecan in children with refractory leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 clinical study evaluating sequential administration of Interleukin-12 followed by Interferon alfa in adults with advanced cancer; th…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating thalidomide for anemia in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: FR901228 in Treating Patients With Hematologic Cancer [Phase 1]
This Phase 1 trial update reports the completion of a study of FR901228 in patients with hematologic cancers, including leukemia and lymphom…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]
A Phase 1/2 study evaluated the safety and preliminary efficacy of combining amifostine with topotecan in patients with leukemia and myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer [Phase 3]
Phase 3 trial evaluating whether St. John's Wort can relieve fatigue in cancer patients undergoing chemotherapy or hormone therapy has compl…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update evaluating a vaccine therapy for patients with myelodysplastic syndromes. The conditions list also includes le…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [Phase 2]
This update reports the termination of a Phase 2 clinical trial investigating removal of T cells to prevent graft-versus-host disease in bon…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
This completed clinical trial investigates metabolic syndrome and related cardiovascular and long-term health effects in adolescent and youn…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Phase 1, Phase 2]
This completed Phase 1/2 trial from UCSF evaluated a conditioning regimen of busulfan, antithymocyte globulin, and fludarabine followed by d…